Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06954740 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Study to Evaluate the Efficacy and Safety of Mesenchymal Stromal Cells (Amimestrocel ) in Patients With Acute Kidney Injury

Study acronym: MSC-AKI-001
StatusRecruiting
PhasePhase 2
Started2025-06-10
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 14, 2026 (before its estimated August 15, 2026 completion). Its status may not reflect the trial's current state.

Amendment history

2026-07-12
Study Status, Arms and Interventions v4
Primary completion date2026-05-15→2026-08-15
2025-09-05
Study Status, Contacts/Locations v3
Study sitesdetails revised at 4 of 6 sites
2025-07-02
Study Status, Contacts/Locations v2
Study sites1→6
2025-06-26
Not Yet Recruiting→Recruiting Study Status, Sponsor/Collaborators, Conditions, Outcome Measures, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2025-05-15→confirmed 2025-06-10
Study sites0→1
Secondary endpointsdetails revised at 1 of 9 entries
2025-04-24
Original filing
This trial is to evaluate the efficacy and safety of Amimestrocel (human umbilical cord mesenchymal stromal cells) in the treatment of AKI patients.
Trial Details
NCT Number NCT06954740
Lead Sponsor Chinese PLA General Hospital
Conditions Acute Kidney Injury
Enrollment 50 participants
Start Date 2025-06-10
Primary Completion 2026-08-15 (estimated)
Study Completion 2028-05-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-14